MedPath

Randomized Controlled Trial of preserving vs resecting residual stomach for Esophageal Cancer after Distal Gastrectomy

Not Applicable
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000049944
Lead Sponsor
Osaka university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Cases with preoperative examination showing non-curative factors such as dissemination, liver metastasis, distant metastasis, etc. Cases of concurrent overlapping cancers Heterochronic overlapping cancers that have recurred after treatment or have been untreated for more than 5 years, or are currently carcinoma-bearing other than gastric cancer. Patients with poorly controlled diabetes mellitus (HbA1c: 8.0 or higher). Patients deemed by the investigator to be inappropriate for the safe conduct of this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath